source
- FDA offers updated guidance for generics of weight loss blockbustersThe FDA revised its draft guidance for generic companies looking to develop copycats of some of the world's best-selling weight loss drugs, including Eli Lilly's Zepbound and Novo Nordisk's Ozempic…
- STAT+: Bracing for another Fauci hearingPlus: Democrats take on Trump over IVF, and Trump's White House releases a new science funding blueprint.